Doctor supervised clinic weight loss with prescribed medication Semaglutide. Please call for a screening to see if Semaglutide medical treatment is right for you.
Semaglutide is a medication that can be used for weight loss management. It can be administered by subcutaneous (under the skin) injections. Patients taking this medication have reported significant weight loss with minimal side effects. The most common side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.
Other less common side effects could include: fatigue, indigestion, heart burn, abdominal distention, belching, hypoglycemia-low blood glucose for type 2 diabetics who also inject insulin, gastroenteritis, GERD-gastroesophageal reflux disease, and in rare cases pancreatitis, gastroparesis and bowel obstruction.
In 2020, Semaglutide was the 129th most prescribed medication in the United States, with more than 4 million prescriptions.
The formulation of Semaglutide is indicated as an adjunct or additional treatment to diet and exercise for long-term weight management in adults with obesity (initial body mass index (BMI) ≥ 30 kg/m 2 ) or who are overweight (initial BMI ≥ 27 kg/m 2 ) and have at least one weight related comorbidity/weight related illness.
Obesity increases health risks, including diabetes, cancer, cardiovascular disease, high blood pressure, and non-alcoholic Fatty Liver Disease to name a few. Reduction of obesity lowers those risks. A 1-kg loss of body weight has been associated with an approximate 1-mm Hg drop in blood pressure. Intentional weight loss is associated with cognitive performance improvements in overweight and obese individuals. It is also noted that weight loss can be a great way to maintain a healthier living to improve physical health, and improve mood and mental health.